PSMAInfo.org - A site for patients with metastatic prostate cancer who are considering Prostate Specific Membrane Antigen (PSMA) imaging and/or therapy.

PSMAInfo.org is a site for patients with non-operable metastatic prostate cancer who are considering Prostate Specific Membrane Antigen (PSMA) imaging and/or therapy.   While much of this information can be used by patients seeking treatment at any medical center using PSMA worldwide, this site focus is on the treatment as provided by Dr. Richard Baum and his team at the Zentralklinik Bad Berka in Bad Berka, Germany. 

As of Jan 1, 2020. Dr. Baum has moved from Zentralklinik Bad Berka and now practices at the THERANOSTICUM Frankfurt-Wiesbadenat DKD Clinic. Please see the article below that details these changes.

As with any site that offers information on treatment or travel, please confirm medical information with your

Read more: Welcome to PSMAinfo.org

As of January 2020, Dr. Baum will be located at the THERANOSTICS CENTER FOR RADIOMOLECULAR PRECISION ONCOLOGY in Wiesbaden  (very close to Frankfurt/Main airport (20 minutes by car or commuter train)). Dr. Baum will have full access to complete diagnostic and treatment facilities. 
As of December 15, 2019, please use the following contact information:

Professor Dr. Richard P. Baum, MD, PhD
THERANOSTICUM Frankfurt-Wiesbaden
at DKD Clinic
Aukammallee 33
65191 Wiesbaden, Germany
https://www.praxis-nuklearmedizin.de/en/
To send an email This email address is being protected from spambots. You need JavaScript enabled to view it.

Dr. Harshad R. Kulkarni, MD, will manage the care of those patients who will still need to be treated at ZBB due to special technical requirements (e.g. ALPHA, intra-arterial

Read more: Dr. Baum's New Location

Introduction to Theranostic from Zentralklink Bad Berka

Speaking at the 12th WARMT ICRT in Vienna

August 2016 Interview on Theranostics for Prostate 

At the 2nd Theranostics World Congress there was progress towards the treatment of metastatic prostate cancer using a Theranostics approach. At the 3rd Theranostics World Congress that progress continued from the bench and to the bedside.

This video is an overview of the treatment and management of metastatic prostate cancer using a Theranostic Approach.

Dosimetry may be used by centers that preform PRLT. Wikipedia defines Dosimetry as "the measurement of the absorbed dose delivered by ionizing radiation, the term is better known as a scientific sub-specialty in the fields of health physics and medical physics, where it is the calculation and assessment of the radiation dose received by the human body."

Below is a talk given by Christiane Schuchardt on how the Theranostics Center in Bad Berka use dosimetry in there daily patient management.

Read more: Understanding Dosimetry
  1. Presentations from the 2nd World Congress on Ga68